Healthcare / Medical Care FacilitiesSaudi
$102.40
+3.40 (+3.43%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $22.9M · quality 45.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
54/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.6B
P/E
15.5x
↓EV/EBITDA
9.5x
↓ROE
17.2%
↑Gross Margin
36.8%
↓Debt/Equity
0.28
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+20.4%
FCF CAGR
+65.9%
FCF margin
1.4%
FCF / Net income
0.07x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.60B · net income $318.5M · FCF $22.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.60B | $1.60B | $1.29B | $1.08B | $917.9M |
| Net Income | $318.5M | $318.5M | $294.7M | $240.9M | $170.1M |
| EBITDA | $484.0M | $484.0M | $396.9M | $323.0M | $244.2M |
| EPS | 7.13 | 7.13 | 6.58 | 5.37 | 3.79 |
| Gross Margin | 36.8% | 36.8% | 34.9% | 34.2% | 31.6% |
| Operating Margin | 22.1% | 22.1% | 19.4% | 22.7% | 21.4% |
| Net Margin | 19.9% | 19.9% | 22.8% | 22.3% | 18.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.28 | 0.28 | 0.30 | 0.23 | 0.07 |
| Current Ratio | 5.16 | 5.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $22.9M | $22.9M | $-6.6M | $412.2M | $5.0M |
| Returns | |||||
| ROE | 17.2% | 17.2% | 18.1% | 16.6% | 13.5% |
| Valuation | |||||
| P/E | 15.52 | 15.52 | 24.38 | 33.78 | 20.24 |
| EV/EBITDA | 9.53 | 9.53 | 18.66 | 25.26 | 13.08 |
| P/B | 2.47 | 2.47 | 4.42 | 5.60 | 2.72 |
| Growth & Yield | |||||
| Revenue Growth | 23.7% | 23.7% | 19.6% | 17.8% | — |
| EPS Growth | 8.4% | 8.4% | 22.5% | 41.7% | — |
| Dividend Yield | 2.9% | 2.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
8.4%
EPS terminal req.
$9.09
Spread vs growth
-0.1%
5Y implied EPS CAGR
9.0%
EPS terminal req.
$10.99
Spread vs growth
-0.7%
10Y implied EPS CAGR
9.5%
EPS terminal req.
$17.71
Spread vs growth
-1.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-35.0%
Start / end P/E
25.1x → 14.4x
EPS bridge
6.58 → 7.13
Residual
-3.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.